Free Trial

Inari Medical (NARI) News Today

Inari Medical logo
$79.55 +0.15 (+0.19%)
As of 01/17/2025 04:00 PM Eastern
Stryker Launches Tender Offer To Acquire Inari Medical For $80/shr
William Blair downgrades Inari Medical (NARI) to a Hold
Inari Medical (NASDAQ:NARI) Rating Lowered to "Hold" at Baird R W
Inari Medical Sees Unusually Large Options Volume (NASDAQ:NARI)
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Director Sells $12,094,000.00 in Stock
Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) Director William Hoffman sold 200,000 shares of the company's stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $60.47, for a total value of $12,094,000.00. Following the completion of the transaction, the director now directly owns 238,987 shares in the company, valued at $14,451,543.89. The trade was a 45.56 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Inari Medical, Inc. stock logo
BTIG Research Reiterates Neutral Rating for Inari Medical (NASDAQ:NARI)
BTIG Research reaffirmed a "neutral" rating on shares of Inari Medical in a research report on Wednesday.
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Lowered to Hold Rating by Baird R W
Baird R W downgraded shares of Inari Medical from a "strong-buy" rating to a "hold" rating in a research report on Tuesday.
Inari Medical downgraded to Hold from Buy at Jefferies
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Earns Equal Weight Rating from Wells Fargo & Company
Wells Fargo & Company reissued an "equal weight" rating and issued a $80.00 price objective (up from $65.00) on shares of Inari Medical in a report on Tuesday.
Inari Medical, Inc. stock logo
Inari Medical Target of Unusually Large Options Trading (NASDAQ:NARI)
Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) was the target of some unusual options trading on Tuesday. Traders purchased 11,622 call options on the stock. This represents an increase of approximately 2,174% compared to the average volume of 511 call options.
Inari Medical, Inc. stock logo
Inari Medical's (NARI) "Market Perform" Rating Reiterated at William Blair
William Blair reaffirmed a "market perform" rating on shares of Inari Medical in a report on Tuesday.
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Sets New 12-Month High on Analyst Upgrade
Inari Medical (NASDAQ:NARI) Sets New 12-Month High After Analyst Upgrade
Inari Medical, Inc. stock logo
Piper Sandler Forecasts Strong Price Appreciation for Inari Medical (NASDAQ:NARI) Stock
Piper Sandler increased their target price on shares of Inari Medical from $52.00 to $80.00 and gave the company a "neutral" rating in a research report on Tuesday.
Inari Medical, Inc. stock logo
Canaccord Genuity Group Reaffirms Hold Rating for Inari Medical (NASDAQ:NARI)
Canaccord Genuity Group reissued a "hold" rating and set a $80.00 price target (up from $74.00) on shares of Inari Medical in a report on Tuesday.
Inari Medical, Inc. stock logo
Robert W. Baird Reaffirms Neutral Rating for Inari Medical (NASDAQ:NARI)
Robert W. Baird reiterated a "neutral" rating and set a $80.00 price target (down from $81.00) on shares of Inari Medical in a research note on Tuesday.
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) has earned an average rating of "Moderate Buy" from the twelve research firms that are currently covering the company, MarketBeat reports. Six research analysts have rated the stock with a hold recommendation and six have assigned a buy recommend
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. lessened its stake in Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 4.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,123,602 shares of the company's stock after selling 47,878 shares
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Shares Down 4.2% - Should You Sell?
Inari Medical (NASDAQ:NARI) Trading Down 4.2% - What's Next?
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Short Interest Up 25.3% in December
Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 3,660,000 shares, a growth of 25.3% from the November 30th total of 2,920,000 shares. Based on an average daily volume of 940,700 shares, the days-to-cover ratio is currently 3.9 days.
Inari Medical, Inc. stock logo
Inari Medical (NASDAQ:NARI) Stock Price Down 4.6% Following Insider Selling
Inari Medical (NASDAQ:NARI) Stock Price Down 4.6% After Insider Selling
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) CEO Sells $165,870.00 in Stock
Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) CEO Andrew Hykes sold 3,000 shares of the business's stock in a transaction on Friday, December 20th. The shares were sold at an average price of $55.29, for a total value of $165,870.00. Following the transaction, the chief executive officer now owns 439,310 shares of the company's stock, valued at approximately $24,289,449.90. The trade was a 0.68 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Shares Acquired by Jane Street Group LLC
Jane Street Group LLC increased its holdings in shares of Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 32.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 95,223 shares of the company's stock after
Inari Medical, Inc. stock logo
Inari Medical, Inc. (NASDAQ:NARI) Director William Hoffman Sells 60,000 Shares
Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) Director William Hoffman sold 60,000 shares of the firm's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $55.66, for a total value of $3,339,600.00. Following the transaction, the director now owns 441,233 shares of the company's stock, valued at $24,559,028.78. This trade represents a 11.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Get Inari Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.

NARI Media Mentions By Week

NARI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NARI
News Sentiment

0.23

0.64

Average
Medical
News Sentiment

NARI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NARI Articles
This Week

2

10

NARI Articles
Average Week

Get Inari Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NARI) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners